HCSGD entry for IFI16


1. General information

Official gene symbolIFI16
Entrez ID3428
Gene full nameinterferon, gamma-inducible protein 16
Other gene symbolsIFNGIP1 PYHIN2
Links to Entrez GeneLinks to Entrez Gene

2. Neighbors in the network

color bar

3. Gene ontology annotation

GO ID

GO term

Evidence

Category

GO:0000122Negative regulation of transcription from RNA polymerase II promoterIDA IMPbiological_process
GO:0001819Positive regulation of cytokine productionTASbiological_process
GO:0002218Activation of innate immune responseIDAbiological_process
GO:0003690Double-stranded DNA bindingIDAmolecular_function
GO:0005515Protein bindingIPImolecular_function
GO:0005634NucleusIDAcellular_component
GO:0005654NucleoplasmIDAcellular_component
GO:0005730NucleolusIDAcellular_component
GO:0005737CytoplasmIDAcellular_component
GO:0005829CytosolTAScellular_component
GO:0006351Transcription, DNA-templatedIEAbiological_process
GO:0006914AutophagyIEAbiological_process
GO:0006954Inflammatory responseIEAbiological_process
GO:0008134Transcription factor bindingIDAmolecular_function
GO:0008283Cell proliferationNASbiological_process
GO:0010506Regulation of autophagyIEPbiological_process
GO:0016607Nuclear speckIDAcellular_component
GO:0030097HemopoiesisNASbiological_process
GO:0030099Myeloid cell differentiationNASbiological_process
GO:0030224Monocyte differentiationIDAbiological_process
GO:0032481Positive regulation of type I interferon productionTASbiological_process
GO:0032731Positive regulation of interleukin-1 beta productionIDAbiological_process
GO:0042149Cellular response to glucose starvationIDAbiological_process
GO:0042771Intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediatorIDAbiological_process
GO:0043392Negative regulation of DNA bindingIDAbiological_process
GO:0045071Negative regulation of viral genome replicationIDAbiological_process
GO:0045087Innate immune responseTASbiological_process
GO:0045824Negative regulation of innate immune responseIDAbiological_process
GO:0045892Negative regulation of transcription, DNA-templatedIDAbiological_process
GO:0045944Positive regulation of transcription from RNA polymerase II promoterIDA IMPbiological_process
GO:0051607Defense response to virusIMPbiological_process
GO:0071479Cellular response to ionizing radiationIDAbiological_process
GO:0072332Intrinsic apoptotic signaling pathway by p53 class mediatorIMPbiological_process
GO:0097202Activation of cysteine-type endopeptidase activityIMPbiological_process
GO:2000117Negative regulation of cysteine-type endopeptidase activityIDAbiological_process
Entries Per Page
Displaying Page of

4. Expression levels in datasets

  • Meta-analysis result

p-value upp-value downFDR upFDR down
0.01760267090.09087540750.32573981740.5731923317

  • Individual experiment result
    ( "-" represent NA in the specific microarray platform )

Data sourceUp or downLog fold change
GSE11954Up0.2091713593
GSE13712_SHEARUp0.5600302865
GSE13712_STATICUp0.1027525107
GSE19018Up0.9994974139
GSE19899_A1Up0.6630920665
GSE19899_A2Down-0.1029552133
PubMed_21979375_A1Down-0.4425910742
PubMed_21979375_A2Up0.4768508512
GSE35957Down-0.6684475514
GSE36640Down-0.5992634794
GSE54402Up0.5219565291
GSE9593Up0.1963801210
GSE43922Down-0.0809192298
GSE24585Down-1.1909222701
GSE37065Up0.3785473781
GSE28863_A1Up0.8695796100
GSE28863_A2Up1.2139993580
GSE28863_A3Down-0.4622708831
GSE28863_A4Down-0.3744363753
GSE48662Down-0.5187463824

5. Regulation relationships with compounds/drugs/microRNAs

  • Compounds

Not regulated by compounds

  • Drugs

Not regulated by drugs

  • MicroRNAs

  • mirTarBase

MiRNA_name

mirBase ID

miRTarBase ID

Experiment

Support type

References (Pubmed ID)

hsa-miR-335-5pMIMAT0000765MIRT017847MicroarrayFunctional MTI (Weak)18185580
hsa-miR-124-3pMIMAT0000422MIRT022657Proteomics;MicroarrayNon-Functional MTI (Weak)18668037
hsa-miR-98-5pMIMAT0000096MIRT027519MicroarrayFunctional MTI (Weak)19088304
hsa-miR-26b-5pMIMAT0000083MIRT029441MicroarrayFunctional MTI (Weak)19088304
Entries Per Page
Displaying Page of
  • mirRecord
No target information from mirRecord

6. Text-mining results about the gene

Gene occurances in abstracts of cellular senescence-associated articles: 9 abstracts the gene occurs.


PubMed ID of the article

Sentenece the gene occurs

27063514IFI16, an amplifier of DNA-damage response: Role in cellular senescence and aging-associated inflammatory diseases
27063514DDR-induced signaling in cells activates the ATM-p53 and ATM-IKKalpha/beta-interferon (IFN)-beta signaling pathways, thus leading to an induction of the p53 and IFN-inducible IFI16 gene
27063514Further, upon DNA-damage, DNA accumulates in the cytoplasm, thereby inducing the IFI16 protein and STING-dependent IFN-beta production and activation of the IFI16 inflammasome, resulting in the production of proinflammatory cytokines (e
27063514Increased expression of IFI16 protein in a variety of cell-types promotes cellular senescence
27063514Because expression of the IFI16 gene is induced by activation of DNA-damage response in cells and increased levels of IFI16 protein in cells potentiate the p53-mediated transcriptional activation of genes and p53 and pRb-mediated cell cycle arrest, we discuss how an improved understanding of the role of IFI16 protein in cellular senescence and associated inflammatory secretory phenotype is likely to identify the molecular mechanisms that contribute to the development of aging-associated human inflammatory diseases and a failure to cancer therapy
24491427IFI16 mis-localization can be a contributing factor to hepatocellular carcinoma progression
24491427Interferon-gamma inducible protein 16 (IFI16), a multifunctional protein, has roles in anti-proliferation, autophagy, cell senescence, anti-inflammation, and DNA sensor to trigger innate immunity
24491427IFI16 physiologically absents in adult healthy hepatocyte, but exists in liver cancer cells
24491427Interestingly, increasing evidences suggest that dysregulation or/and loss of IFI16 function have a critical role in drug resistance and tumor progression
24491427In our study, to our knowledge, we first showed that IFI16 is a chromatin-binding protein in four HCC cell lines with different TP53 genotype, but not in fetal liver cell line, L02 cells
21471287Differential roles for the interferon-inducible IFI16 and AIM2 innate immune sensors for cytosolic DNA in cellular senescence of human fibroblasts
21471287The IFN-inducible IFI16 and AIM2 proteins act as innate immune sensors for cytosolic double-stranded DNA (dsDNA)
21471287On sensing dsDNA, the IFI16 protein induces the expression of IFN-beta whereas the AIM2 protein forms an inflammasome, which promotes the secretion of IL-1beta
21471287Given that the knockdown of IFI16 expression in human diploid fibroblasts (HDF) delays the onset of cellular senescence, we investigated the potential roles for the IFI16 and AIM2 proteins in cellular senescence
21471287We found that increased IFI16 protein levels in old (vs
21471287The knockdown of type I IFN-alpha receptor subunit, which reduced the basal levels of the IFI16 but not of the AIM2, protein delayed the onset of cellular senescence
21471287Accordingly, increased constitutive levels of IFI16 and AIM2 proteins in ataxia telangiectasia mutated (ATM) HDFs were associated with the activation of the IFN signaling and increased levels of IL-1beta
21471287The IFN-beta treatment of the young HDFs, which induced the expression of IFI16 and AIM2 proteins, activated a DNA damage response and also increased basal levels of IL-1beta
21471287Interestingly, the knockdown of AIM2 expression in HDFs increased the basal levels of IFI16 protein and activated the IFN signaling
21471287In contrast, the knockdown of the IFI16 expression in HDFs decreased the basal and dsDNA-induced activation of the IFN signaling
21471287Collectively, our observations show differential roles for the IFI16 and AIM2 proteins in cellular senescence and associated secretory phenotype
20052289Interferon-inducible IFI16, a negative regulator of cell growth, down-regulates expression of human telomerase reverse transcriptase (hTERT) gene
20052289BACKGROUND: Increased levels of interferon (IFN)-inducible IFI16 protein (encoded by the IFI16 gene located at 1q22) in human normal prostate epithelial cells and diploid fibroblasts (HDFs) are associated with the onset of cellular senescence
20052289Here, we report that increased levels of IFI16 protein in normal HDFs and in HeLa cells negatively regulate the expression of human telomerase reverse transcriptase (hTERT) gene
20052289Using the optimized conditions, we report that treatment of HDFs with inhibitors of cell cycle progression, such as aphidicolin or CGK1026, which resulted in reduced steady-state levels of IFI16 mRNA and protein, was associated with increases in hTERT mRNA and protein levels and telomerase activity
20052289In contrast, knockdown of IFI16 expression in cells increased the expression of c-Myc, a positive regulator of hTERT expression
20052289Additionally, over-expression of IFI16 protein in cells inhibited the c-Myc-mediated stimulation of the activity of hTERT-luc-reporter and reduced the steady-state levels of c-Myc and hTERT
20052289CONCLUSIONS/SIGNIFICANCE: These data demonstrated that increased levels of IFI16 protein in HDFs down-regulate the expression of hTERT gene
20052289Our observations will serve basis to understand how increased cellular levels of the IFI16 protein may contribute to certain aging-dependent diseases
19071156Knockdown of ATM kinase or IFI16 rescued IFN-gamma-induced cellular senescence
18974396Expression of an IFN-inducible cellular senescence gene, IFI16, is up-regulated by p53
18974396IFN-inducible IFI16 protein (encoded by IFI16 gene at 1q23
18974396Increased expression of the IFI16 protein, a positive modulator of p53-mediated transcription, in normal old human diploid fibroblasts (HDF) is associated with cellular senescence-mediated cell growth arrest
18974396However, the underlying mechanisms that contribute to transcriptional activation of the IFI16 gene in old HDFs remain to be elucidated
18974396Here, we reported that functional activation of p53 in normal young HDFs and p53-null Saos2 cell line resulted in transcriptional activation of the IFI16 gene
18974396We identified a potential p53 DNA-binding site (indicated as IFI16-p53-BS) in the 5'-regulatory region of the IFI16 gene
18974396Furthermore, p53 associated with the 5'-regulatory region of the IFI16 gene in chromatin immunoprecipitation assays
18974396Interestingly, p53 associated with the regulatory region of the IFI16 gene only on treatment of cells with DNA-damaging agents or in the old, but not in the young, HDFs
18974396Importantly, our promoter-reporter assays, which were coupled with site-directed mutagenesis of IFI16-p53-BS, showed that p53 activates transcription of the IFI16 gene in HDFs through the p53 DNA-binding site
18974396Together, our observations provide support for the idea that up-regulation of IFI16 expression by p53 and functional interactions between IFI16 protein and p53 contribute to cellular senescence
17981573Interferon-inducible IFI16 protein in human cancers and autoimmune diseases
17981573Interferon-inducible IFI16 protein (encoded by IFI16 gene located at 1q21 region) is a member of the p200-protein family
17981573Consistent with this role of p200-family proteins, increased expression of IFI16 protein in normal human diploid fibroblasts and prostate epithelial cells is associated with cellular senescence-associated permanent cell growth arrest
17981573Furthermore, reduced or loss of IFI16 expression in cells is associated with the development of certain cancers, such as breast and prostate cancer
17981573Interestingly, recent studies have provided evidence that the constitutive and interferon-induced expression of the IFI16 gene varies among individuals and may depend on the race
17981573These studies raise the possibility that alterations (increases or decreases) in the expression of IFI16 protein may contribute to the development of human diseases
17981573In this review, we discuss how our understanding of the regulation of IFI16 expression and its role in cell growth regulation will help elucidate the molecular mechanisms that contribute to the development of various human diseases
17569615IFI16 inhibits tumorigenicity and cell proliferation of bone and cartilage tumor cells
17569615IFI16 is a member of the interferon-inducible p200-protein family, capable of modulating cell proliferation, and cellular senescence
17569615In this study, these effects of IFI16 were studied in tumor cells derived from bone and cartilage
17569615The level of IFI16 was markedly lower in human osteosarcomas as compared with its level in normal bone
17569615Overexpression of functional IFI16 in human osteosarcoma and chondrosarcoma cell lines markedly inhibited colony formation, and significantly inhibited cell growth, an effect that could be reversed by introduction of gene specific siRNA into tumor cells
17569615These inhibitory effects of IFI16 were associated with upregulation of p21 and inhibition of cyclin E, cyclin D1, c-Myc and Ras
17569615In addition, ectopic expression of IFI16 in tumor cells increased senescence-associated beta-galactosidase and induced a senescence-like phenotype
17569615In view of such effects, IFI16 might be a suitable target for therapeutic intervention in osteosarcoma and chondrosarcoma
17339605IFI16 in human prostate cancer
17339605Increased expression of IFI16 protein (encoded by the IFI16 gene) in normal human prostate epithelial cells is associated with cellular senescence-associated cell growth arrest
17339605Consistent with a role for IFI16 protein in cellular senescence, the expression of IFI16 protein is either very low or not detectable in human prostate cancer cell lines
17339605We now report that treatment of DU-145 and LNCaP prostate cancer cell lines with histone deacetylase inhibitor trichostatin A (TSA) or CGK1026 resulted in transcriptional activation of the IFI16 gene
17339605The induction of IFI16 protein in LNCaP cells was dependent on the duration of TSA treatment
17339605However, overexpression of exogenous Janus-activated kinase 1 protein in LNCaP cells and treatment of cells with IFNs (alpha and gamma) did not increase the expression of IFI16
17339605Instead, the transcriptional activation of IFI16 gene by TSA treatment of LNCaP cells was dependent on transcriptional activation by c-Jun/activator protein-1 transcription factor
17339605Importantly, increased expression of IFI16 in LNCaP cells was associated with decreases in the expression of androgen receptor and apoptosis of cells
17339605Conversely, knockdown of IFI16 expression in TSA-treated LNCaP cells increased androgen receptor protein levels with concomitant decreases in apoptosis
17339605Together, our observations provide support for the idea that histone deacetylase-dependent transcriptional silencing of the IFI16 gene in prostate epithelial cells contributes to the development of prostate cancer
Entries Per Page
Displaying Page of